Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial
批准号:
10417065
负责人:
Robert J Ferguson
金额:
$58.53万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31
关键词:
AddressAftercareAttentionBehavioralBrainBrain InjuriesBrain regionBreast Cancer survivorBreast Cancer survivorshipCancer CenterCancer SurvivorCaringClinicalCognitiveCognitive TherapyControl GroupsDataDevelopmentEvidence based treatmentFailureFinancial compensationFosteringFoundationsFunctional Magnetic Resonance ImagingGoalsHealth Services AccessibilityImpaired cognitionIndividualInterventionLeadLifeLinkMemoryMethodologyModificationNeurobehavioral ManifestationsNeurocognitiveOutcomeOutcome MeasureParticipantPatient Self-ReportPatientsPatternPerformancePersonal SatisfactionPharmaceutical PreparationsPhysical activityPilot ProjectsPlacebosPopulationProcessPublishingQuality of lifeRandomizedRandomized Controlled TrialsRecoveryRehabilitation therapyResearchRiskRitalinRuralSample SizeSecureSelf ManagementSelf PerceptionShort-Term MemorySiteSupportive careSurvivorsTask PerformancesTestingTimeTrainingTraumatic Brain InjuryTravelVideoconferencingVisitWaiting ListsWorkactive controlattentional controlbasecancer carechemotherapycognitive changecognitive enhancementcognitive functioncognitive performancecognitive trainingcomputerizedcontrol trialcopingdensitydesigndisabilityeffective therapyefficacy evaluationemotion regulationemotional adjustmentexperiencefollow up assessmentfollow-upfrontal lobegray matterhandheld mobile devicehealth care settingsimprovedmalignant breast neoplasmmindfulnessmobile computingneuroimagingnon-drugnondrug therapypersonalized interventionpillprimary outcomeprocessing speedpublic health prioritiesrandomized trialrural areasurvivorshiptherapy developmenttranslational potential
中文摘要
摘要
这项拟议的研究将检验视频会议传递的认知行为疗法的有效性。
(CBT),记忆和注意力适应训练(MAAT),在一项大型、多点、随机对照试验中
(RCT)适用于患有化疗相关认知功能障碍(CRCD)的乳腺癌幸存者。结果
测量包括主观和客观认知功能的评估。另一个目标是
研究是使用功能磁共振(FMRI)来评估大脑激活模式的潜在变化,这些变化
据信与MAAT的积极作用有关。MPI最近的分析表明
MAAT治疗后与工作记忆相关的皮层激活增强
创伤性脑损伤(TBI)。目前的工作试图确定相同的激活模式是否发生在
乳腺癌幸存者的MAAT治疗与注意力控制条件(支持性治疗;ST)的比较。如果
如果成功,这项工作的结果将是:(1)产生一种循证治疗,可以立即
传播到癌症中心和其他医疗机构,以治疗CRCD和(2)帮助进一步了解
通过更好地了解促进慢性阻塞性肺疾病康复的机制来开发治疗方法。MAAT
使用非药物、CBT方法来增强自我管理、行为适应和应对迟缓
化疗的认知影响。MAAT已经在之前的四个小规模试验中进行了评估:1)单一组
试点研究(NCI R03);2)随机等待名单对照试验(兰斯·阿姆斯特朗基金会);3)和随机对照试验
使用MAAT和ST干预的积极对照组条件(支持性治疗;ST)的试验
都是通过视频会议(NCI R21)进行的。对乳腺癌幸存者的研究显示出有希望的结果
主客观认知功能均有改善。在第四个试验中,有认知症状的个体
创伤性脑损伤(TBI)后单独或联合应用MAAT可改善认知功能。
与接受行为或药片安慰剂的患者相比,联合使用哌醋甲酯。虽然到目前为止的研究
MAAT是有利的,尚未在独立、多名临床医生或多名临床医生参与的大型随机对照试验中进行评估
在乳腺癌人群中建立有效性和普适性的站点。只有一名临床医生接生
MAAT在以前的乳腺癌生存研究中,样本量很小。因此,
拟议的研究在多个地点使用更大的样本量进行了重要的方法改进,
具有ST控制条件的多临床医生RCT,并通过提供这两种方案来减少幸存者的旅行负担
MAAT和ST通过安全的视频会议链路。因此,拟议的研究具有很大的潜力
临床和科学影响,并将有助于提供有效的非药物治疗,可以广泛
利用移动技术传播,特别是向农村幸存者传播,以减少旅行和时间负担
改善生存护理。
英文摘要
ABSTRACT
The proposed research will examine the efficacy of a videoconference-delivered cognitive-behavioral therapy
(CBT), Memory and Attention Adaptation Training (MAAT), in a large, multi-site, randomized controlled trial
(RCT) for breast cancer survivors with chemotherapy-related cognitive dysfunction (CRCD). Outcome
measures include assessment of both subjective and objective cognitive functioning. Another goal of the
research is to use functional MRI (fMRI) to evaluate underlying changes in brain activation patterns that are
believed to be associated with positive effects of MAAT. Recent analyses by the MPIs have demonstrated
enhanced working memory-related cortical activation following MAAT treatment among individuals with
traumatic brain injury (TBI). The present work seeks to determine if the same activation patterns occur post-
treatment with MAAT vs. an attention control condition (supportive therapy; ST) in breast cancer survivors. If
successful, the results of this work will: (1) produce an evidence-based treatment that can be immediately
disseminated to cancer centers and other healthcare settings to treat CRCD and (2) help inform further
treatment development through improved understanding of mechanisms that promote CRCD recovery. MAAT
utilizes a non-drug, CBT approach to enhance self-management, behavioral adaptation, and coping with late
cognitive effects of chemotherapy. MAAT has been evaluated in four previous small trials: 1) a single-group
pilot study (NCI R03); 2) a randomized waitlist control trial (Lance Armstrong Foundation); 3) and a randomized
trial with an active control group condition (supportive therapy; ST) in which both MAAT and ST interventions
were delivered via videoconference (NCI R21). Research with breast cancer survivors shows promising results
with improved subjective and objective cognitive function. In a fourth trial, individuals with cognitive symptoms
after traumatic brain injury (TBI) showed improved cognitive function when treated with MAAT alone or in
combination with methylphenidate relative to those receiving behavioral or pill placebo. While research to date
is favorable, MAAT has not been evaluated in a large RCT with independent, multiple clinicians or at multiple
sites to establish efficacy and generalizability in the breast cancer population. Only one clinician has delivered
MAAT in previous breast cancer survivorship studies and the sample sizes were small. Therefore, the
proposed study makes important methodological improvements using a larger sample size in a multi-site,
multi-clinician RCT with an ST control condition, and reduces survivorship travel burden by delivering both
MAAT and ST over secured videoconference link. The proposed study therefore has the potential for great
clinical and scientific impact, and will help offer effective non-pharmacologic treatment that can be widely
disseminated using mobile technology, especially to rural survivors, to reduce travel and time burden and
improve survivorship care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial
-
批准号:10652586
-
项目类别:
-
资助金额:$59.23万
-
财政年份:2020
-
负责人:Robert J Ferguson
-
依托单位:
Videoconference CBT for Rural Breast Cancer Survivors with Cognitive Complaints
-
批准号:8047754
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2011
-
负责人:Robert J Ferguson
-
依托单位:
Videoconference CBT for Rural Breast Cancer Survivors with Cognitive Complaints
-
批准号:8325524
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2011
-
负责人:Robert J Ferguson
-
依托单位:
海外基金